Assurance from the Fed that rising prices are transitory coupled
with falling U.S. Treasury yields have helped ease some concerns
over inflation but investors remain cautious as they await the
Fed's commentary on its inflation stance.
The benchmark S&P 500, the blue-chip Dow Jones and the
tech-stocks focused Nasdaq have gained 13.3%, 12.3% and 10%,
respectively so far this year as investors tried to find their
ground between inflation concerns and optimism about an economic
reopening.
The Fed is likely to announce in August or September a strategy
for reducing its massive bond buying program, but won't start
cutting monthly purchases until early next year, a Reuters poll
of economists found.
At 6:50 a.m. ET, Dow e-minis were down 10 points, or 0.03%, S&P
500 e-minis were up 2.75 points, or 0.06%, and Nasdaq 100
e-minis were up 16.75 points, or 0.12%.
In a new policy statement and economic projections due on
Wednesday, the U.S. central bank is expected to point to
continued strength in the economy and acknowledge the first
conversations among its policymakers about when and how fast to
pare back the massive bond-buying program.
In corporate news, Biogen Inc fell 0.9% in premarket trading
after the drugmaker's potential therapy for choroideremia, an
inherited disease that leads to vision loss, did not meet the
main goal in a late-stage study.
Later in the day, investors would turn to purchaser price
numbers and retail sales data to assess the state of the economy
and inflation levels.
(Reporting by Shashank Nayar in Bengaluru; Editing by Maju
Samuel)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|